Optically driven microtools with an antibody‐immobilised surface for on‐site cell assembly

Abstract

To enable the accurate reproduction of organs in vitro, and improve drug screening efficiency and regenerative medicine research, it is necessary to assemble cells with single‐cell resolution to form cell clusters. However, a method to assemble such forms has not been developed. In this study, a platform for on‐site cell assembly at the single‐cell level using optically driven microtools in a microfluidic device is developed. The microtool was fabricated by SU‐8 photolithography, and antibodies were immobilised on its surface. The cells were captured by the microtool through the bindings between the antibodies on the microtool and the antigens on the cell membrane. Transmembrane proteins, CD51/61 and CD44 that facilitate cell adhesion, commonly found on the surface of cancer cells were targeted. The microtool containing antibodies for CD51/61 and CD44 proteins was manipulated using optical tweezers to capture HeLa cells placed on a microfluidic device. A comparison of the adhesion rates of different surface treatments showed the superiority of the antibody‐immobilised microtool. The assembly of multiple cells into a cluster by repeating the cell capture process is further demonstrated. The geometry and surface function of the microtool can be modified according to the cell assembly requirements. The platform can be used in regenerative medicine and drug screening to produce cell clusters that closely resemble tissues and organs in vivo.

Optofluidic Tweezers: Efficient and Versatile Micro/Nano-Manipulation Tools

“…Copyright @ 2020 MDPI. ( c ) Principle of a cellular assembly platform in a microfluidic device, reproduced with permission from [ 139 ]. Copyright @ 2023 John Wiley & Sons, Inc.…”

“…Each peak corresponds to a specific molecu- In addition, optofluidic tweezers incorporating antigen-antibody interactions can perform some specific tasks due to the specificity and efficiency of antigen-antibody interactions. In 2023, Mori et al developed a platform for in situ cell assembly in a microfluidic device using optically driven micro-tools (Figure 8c) [139]. Antibodies immobilized on the micro-tool bind to antigens on the cell membrane and are captured by the micro-tool.…”